When was Praxis Medicines founded?

Praxis Medicines was founded in 2015 and raised its 1st funding round 5 years after it was founded.

Where is Praxis Medicines located?

Praxis Medicines is headquartered in Boston, United States. It is registered at Cambridge, Massachusetts.

How many employees does Praxis Medicines have?

As of May 31, 2026, the latest employee count at Praxis Medicines is 230.

Is Praxis Medicines a funded company?

Praxis Medicines is a funded company, having raised a total of $***** in its 1st and only funding round, a Series C round on May 04, 2020.

When was the latest funding round of Praxis Medicines?

Praxis Medicines' latest funding was a $***** Series C round on May 04, 2020, with participation from 12 investors.

What is the annual revenue of Praxis Medicines?

Annual revenue of Praxis Medicines is between $1M and $10M as on Dec 31, 2024

Where does Praxis Medicines rank among its competitors?

Praxis Medicines ranks 81st amongst 2822 active competitors, of which 977 are funded. It stands 9th in terms of total funding among its competitors. The most recent competitor to raise funding was Karyopharm, which secured $30M in Mar, 2026.

Who are the top competitors of Praxis Medicines?

Praxis Medicines' top competitors include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Among them, Karyopharm secured the most recent funding round in March, 2026.

Praxis Medicines - 2026 Company Profile, Funding, Competitors & Financials

Company Details

Developer of therapies to treat brain disorders. The company has developed Prax-114 to treat mood disorders, Prax-994 to treat movement disorders such as epilepsy, Prax-222 to treat genetic epilepsies, Prax-562 to treat pain disorders, and Prx-120 to treat genetic epilepsies.

Website: praxismedicines.com
Email ID: *****@praxismedicines.com
Phone Number: +1 **********
Registered Address: Cambridge, Massachusetts

Key Metrics

Founded Year

2015

Location

Boston, United States

Stage

Public

Total Funding

$110M in 1 round

Latest Funding Round

Series C, May 04, 2020, $*****

Investors

Eventide Funds & 11 more

Ranked

81^st among 2822 active competitors

Annual Revenue

$1M - $10M as on Dec 31, 2024

Employee Count

230 as on May 31, 2026

Similar Companies

Jazz Pharmaceuticals & 552 more

Exit Details

Public

View Praxis Medicines' full profile

Praxis Medicines is associated with 2 legal entities given below:

Legal Entity Name	Date of Incorporation	Revenue	Latest Employee Count	Documents
Praxis Precision Medicines, Inc. CIN: 475195942 , United States, Active	Dec 31, 1999	$1M - $10M (As on Dec 31, 2024)	105 (As on Dec 31, 2024)	-
Praxis Precision Medicines, Inc. CIN: 001t000000WoaQNAAZ , United States, Active	Sep 16, 2020	-	-	-

Praxis Medicines got listed on Oct 16, 2020.

Click here to take a look at Praxis Medicines's IPO in detail

Praxis Medicines has raised a total funding of $110M over 1 round. Its latest funding round was a Series C round on May 04, 2020 for $*****. 12 investors participated in its latest round. Praxis Medicines has 12 institutional investors.

Here is the list of recent funding rounds of Praxis Medicines:

Date of Funding	Funding Amount	Round Name	Post-Money Valuation	Revenue Multiple	Lead Investors	Other Investors
May 04, 2020	3606864	Series C	4839559	2136596	3367051	9212039

Access funding benchmarks and valuations. Sign up today!

View details of Praxis Medicines's funding rounds and investors

Praxis Medicines' employee count trend

Praxis Medicines has 230 employees as of May 26. Here is Praxis Medicines's employee count trend over the years:

Employee count trend for Praxis Medicines

Uncover Praxis Medicines' growth story! Sign up today!

Access Tracxn on any website

Our Google Chrome extension lets you view company details while browsing their websites

Install Tracxn Extension

Top competitors of Praxis Medicines include Jazz Pharmaceuticals, Biogen and PTC Therapeutics. Here is the list of Top 10 competitors of Praxis Medicines, ranked by Tracxn score:

Rank	Company Details	Short Description	Total Funding	Investors	Tracxn Score
1st	Jazz Pharmaceuticals 2003, Dublin (Ireland), Public	Developer of novel biopharmaceutical medicines for unmet medical needs	$265M	Versant Ventures, Prospect Venture Partners ... & 14 others	82/100
2nd	Biogen 1978, Cambridge (United States), Public	Developer of therapies for neurodegenerative and immunology disorders	$80M	Berkshire Hathaway, Gershon Capital & 10 others	78/100
3rd	PTC Therapeutics 1998, South Plainfield (United States), Public	Developer of small molecule drugs for the treatment of rare diseases	$248M	HBM Healthcare Investments, Credit Suisse First Boston ... & 27 others	77/100
4th	Sana Biotechnology 2018, Seattle (United States), Public	Developer of engineered cell therapies for treating human disease conditions	$821M	Baillie Gifford, Bezos Expeditions & 17 others	75/100
5th	Blueprint Medicines 2008, Cambridge (United States), Acquired	Developer of selective kinase inhibitors for patients with genomically defined cancers	$115M	Nextech Invest, Third Rock Ventures & 20 others	72/100
6th	Ideaya Biosciences 2015, San Francisco (United States), Public	Developer of oncology-focused precision medicine using molecular diagnostics	$157M	Boxer Capital, BVF Partners & 15 others	72/100
7th	Kronos Bio 2017, San Mateo (United States), Acquired	Developer of small molecule based therapeutics for cancer treatment	$271M	Omega Funds, Vida Ventures & 18 others	72/100
8th	Sutro Biopharma 2003, United States, Public	Developer of antibody-based therapeutics for cancer therapy	$175M	Skyline Ventures, Alta Partners & 17 others	72/100
9th	Syndax 2005, Waltham (United States), Public	Developer of targeted therapies for the treatment of cancer	$198M	Fidelity Investments, Domain Associates & 19 others	72/100
10th	Karyopharm 2008, Natick (United States), Public	Developer of small molecule drugs for the treatment of cancer and inflammatory disease	$98.4M	Foresite Capital, Avidity Partners & 16 others	71/100
81st	Praxis Medicines 2015, Boston (United States), Public	Developer of therapies to treat brain disorders	$110M	Avoro Capital, Qatar Investment Authority ... & 10 others	64/100

Get insights and benchmarks for competitors of 2M+ companies! Sign up today!

Looking for more details on Praxis Medicines's competitors? Click here to see the top ones

Praxis Medicines has made no investments or acquisitions yet.

Media has covered Praxis Medicines for a total of 38 events in the last 1 year, 15 of them have been about company updates and 2 about people movement.